Equity Overview
Price & Market Data
Price: $4.26
Daily Change: -$0.04 / 0.94%
Daily Range: $4.26 - $4.26
Market Cap: $1,272,431,872
Daily Volume: 300
Performance Metrics
1 Week: -0.93%
1 Month: -0.93%
3 Months: -11.24%
6 Months: 118.5%
1 Year: 442.1%
YTD: -11.24%
About DBV TECHNOLOGIES (DBVTF)
Discover the financial pulse of DBV TECHNOLOGIES (DBVTF). Current price: 4.26, daily change: -$0.04 / 0.94%. Market cap: 1,272,431,872. Get YTD and 52-week performance.
Company Details
Employees: 125
Sector: Health technology
Industry: Pharmaceuticals: major
Country: France
Details
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.